169032-01-3 Usage
Uses
Used in Pharmaceutical Research:
(R)-2-AMINO-1-(3-CHLOROPHENYL) ETHANOL HYDROCHLORIDE is used as a research compound for studying β3-adrenergic receptor agonistic activity. This application is significant because β3-adrenergic receptors play a crucial role in various physiological processes, including metabolism, thermogenesis, and smooth muscle relaxation. Modulating these receptors can lead to the development of novel therapeutic strategies for conditions such as obesity, diabetes, and urinary incontinence.
Used in Chemical Synthesis:
In the chemical industry, (R)-2-AMINO-1-(3-CHLOROPHENYL) ETHANOL HYDROCHLORIDE can be used as a building block or intermediate in the synthesis of more complex molecules. Its unique structure and functional groups make it a valuable component for creating new compounds with specific properties and applications.
Used in Analytical Chemistry:
The compound can also be employed in analytical chemistry as a reference material or standard for the development and validation of analytical methods. Its distinct chemical properties and stereochemistry make it suitable for use in high-performance liquid chromatography (HPLC), gas chromatography (GC), and other separation techniques to study enantiomeric purity and resolve chiral compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 169032-01-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,0,3 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 169032-01:
(8*1)+(7*6)+(6*9)+(5*0)+(4*3)+(3*2)+(2*0)+(1*1)=123
123 % 10 = 3
So 169032-01-3 is a valid CAS Registry Number.
169032-01-3Relevant academic research and scientific papers
Imidazole based kinase inhibitors
-
Page/Page column 9, (2008/06/13)
The present invention provides compounds having Formula I and their use for the treatment of cancer.
Benzimidazole C-2 heterocycles as kinase inhibitors
-
Page/Page column 12, (2010/02/11)
Benzimidazole derivatives having the general formula I are provided. These compounds are useful as tyrosine kinase inhibitors, especially for the treatment of cancer.
NOVEL TYROSINE KINASE INHIBITORS
-
Page 34, (2008/06/13)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents.
Novel tyrosine kinase inhibitors
-
Page 21, (2010/11/30)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.
